Tesla reported Q2 earnings on Tuesday evening, and the stock is trading at $378.93 — down 4.4% on the week but up 2.5% on the day, which tells you the immediate reaction was relief relative to what options traders had been bracing for.
The options picture has unwound materially from the defensive extreme flagged in last week's notes. The put/call ratio has dropped back to 0.77, essentially in line with its 20-day average of 0.75 — a z-score of just 0.85. Two weeks ago the same ratio was running above two standard deviations. That collapse in hedging demand after the print is consistent with a result that didn't produce the sharp downside the options market was pricing. The April precedent — a 3.3% day-one drop — turns out to be roughly what happened this cycle too, with the stock clawing back most of that on Wednesday. The borrow market remains irrelevant to this story. Availability is as loose as it gets, with over 9,900% of short interest available to lend. Cost to borrow has drifted higher over the past month — up about 34% — but the absolute level of 0.36% is trivially cheap. Nothing in the lending market suggests any squeeze pressure.
Short interest, meanwhile, has done what it has done for months: almost nothing. SI has eased to 2.3% of the free float, down from 3.0% earlier in July. That decline reflects shorts covering modestly into the print — not a new conviction trade in either direction. The ORTEX short score is a steady 31.6, barely changed across the past two weeks. The short book has now sat passive through a 6.6% decline into earnings and a partial recovery out of it. That passivity is either a signal of profound indifference or of a cohort that has already sized down and has no appetite to rebuild. Either way, it is not the story.
The Street story is more interesting, and the data has shifted since the pre-earnings notes. Analyst targets were already moving up before the print — Morgan Stanley to $417, UBS to $442, RBC to $500 — and the consensus mean landed near $425. With the stock now at $379, that consensus implies roughly 12% upside, but the distribution of views is extremely wide. GLJ Research reiterated its Sell with a $24.86 target on July 21 — a number that implies the stock is worth roughly a sixteenth of its current price, which the data-consistency check flags as an extreme outlier reflecting a structurally different thesis rather than a valuation dispute. Stripping that out, the bulk of the Street is clustered in the $370–$500 range, with most names at Equal-Weight or Neutral. The valuation context supports the caution: the trailing P/E is 159x and the EV/EBITDA is 78x. The 30-day move in the P/E has been a compression of about 19 points — the stock de-rated meaningfully through June and early July before Tuesday's bounce. On the factor side, EPS momentum over 30 days ranks in the 85th percentile, a strong reading that reflects upward estimate revisions. EPS surprise, however, ranks only in the 12th percentile — the company has not been consistently beating.
The insider data adds one notable postscript. Elon Musk sold 17.5 million shares on June 16 for roughly $7.1 billion at an average of $404.66. That transaction was flagged in last week's coverage and predates the Q2 print. At $379, the stock is now trading below that sale price. The CFO also sold a small tranche in early June. There has been no insider buying reported in the 90-day window. That asymmetry — CEO selling at $405, stock now at $379 — is descriptive, not directional, but it is worth noting as the market digests the Q2 numbers.
The question that now resolves from weeks of pre-earnings positioning is whether the short book uses any post-earnings dip as an entry point or continues to sit on its hands. SI has trended gently lower across July. Cost to borrow has drifted higher without becoming restrictive. The next catalyst worth watching is whether Q2 results shift the estimate trajectory — the 85th-percentile EPS momentum rank will either hold or roll over depending on how the Street updates its models over the next two weeks.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
